Viking Therapeutics (NASDAQ:VKTX – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.02, Briefing.com reports. The firm’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.02, Briefing.com reports. Viking Therapeutics’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period […]
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) fell 5.5% during mid-day trading on Monday . The company traded as low as $14.50 and last traded at $14.51. 730,293 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 3,481,354 shares. The stock had previously closed at […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, July 26th. Analysts expect Viking Therapeutics to post earnings of ($0.21) per share for the quarter. Viking Therapeutics (NASDAQ:VKTX – Get Free Report) last issued its quarterly earnings data on Wednesday, April 26th. The biotechnology […]
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) dropped 6.1% during mid-day trading on Friday . The stock traded as low as $20.46 and last traded at $20.48. Approximately 788,148 shares changed hands during trading, a decline of 77% from the average daily volume of 3,490,608 shares. The stock had previously closed at $21.80. […]